[Skip to Navigation]
News From the Food and Drug Administration
May 19, 2020

Generic Albuterol Inhaler Approved

JAMA. 2020;323(19):1887. doi:10.1001/jama.2020.7282

The FDA has approved the first generic version of Proventil HFA Metered Dose Inhaler, 90 μg per inhalation, to treat or prevent bronchospasm in patients aged 4 years or older who have reversible obstructive airway disease. The generic albuterol sulfate inhaler also is indicated for exercise-induced bronchospasm prevention in the same age group.